Loading
Every connected record, the notes, the JSON, Markdown and RDF twins, and where the record came from and when it was checked.
Direct links plus the targets, companies, and technologies of this cancer's products.
Shares After Hodgkin lymphoma: the late effects, and the screening that follows them, Central venous access (port, PICC line), Late effects of Hodgkin lymphoma treatment, and the follow-up that answers them, Radiotherapy in lymphoma: involved-site fields, 24 Gy, 4 Gy and total skin electron therapy and the tags subtype-page, haematologic.
Shares FDG PET, IMRT / IGRT (modern external beam) and the tags subtype-page, haematologic.
Shares Allogeneic stem cell transplantation and the tags subtype-page, haematologic.
Shares FDG PET and the tags subtype-page, haematologic.
Shares the tags subtype-page, haematologic.
Shares Treatment at the local hospital or at a cell-therapy centre far from home, ctDNA monitoring in lymphoma (PhasED-seq, clonoSEQ), Fertility before lymphoma treatment: what to ask for, and when, Low antibodies and infection risk for years after anti-CD20 and bispecific antibodies and the tag subtype-page.
Shares Low antibodies and infection risk for years after anti-CD20 and bispecific antibodies, Central venous access (port, PICC line), Hypogammaglobulinaemia and infection risk after B-cell therapies, Radiotherapy in lymphoma: involved-site fields, 24 Gy, 4 Gy and total skin electron therapy and the tags subtype-page, haematologic.
Shares A clinical trial or standard treatment in lymphoma, Fatigue after lymphoma treatment, and why it is a symptom to report, Low antibodies and infection risk for years after anti-CD20 and bispecific antibodies, Central venous access (port, PICC line) and the tag haematologic.
The same record for scripts and assistants; checked 2026-09-18. Data CC BY-NC 4.0, attribute “Data from OnCo (onco.cc)”.